AmpliTech Gr (NASDAQ:AMPG) reported quarterly sales of $5.40 million which beat the analyst consensus estimate of $4.25 million by 27.06 percent. This is a 410.88 percent increase over sales of $1.06 million the same period last year.
Ardelyx To Present Additional Data Supporting First-In-Class IBSRELA For Adults With Irritable Bowel Syndrome With Constipation At The 2024 Digestive Disease Week Conference
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that
